Jeng‐Kai Jiang
YOU?
Author Swipe
View article: Population-specific polygenic risk scores for people of Han Chinese ancestry
Population-specific polygenic risk scores for people of Han Chinese ancestry Open
Predicting complex disease risks on the basis of individual genomic profiles is an advancing field in human genetics1,2. However, most genetic studies have focused on populations of European ancestry, creating a global imbalance…
View article: Prognostic impact of metastatic sites and its metastasectomy in colorectal cancer: a retrospective analysis from a single institution
Prognostic impact of metastatic sites and its metastasectomy in colorectal cancer: a retrospective analysis from a single institution Open
View article: Endoscopic submucosal dissection as an alternative management for huge colon lipoma with acute intussusception
Endoscopic submucosal dissection as an alternative management for huge colon lipoma with acute intussusception Open
View article: Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer Open
Moderate doses of bevacizumab and TAS-102 provided satisfactory efficacy over the standard dose within a limited timeframe of 9.5 months.
View article: Reply to: “Does ‘the different study period’ influence outcome evaluation?”
Reply to: “Does ‘the different study period’ influence outcome evaluation?” Open
View article: Short-term outcomes of short- and long-course chemoradiotherapy before total mesorectal excision for locally advanced rectal tumors: A single-center study in Taiwan utilizing propensity score matching
Short-term outcomes of short- and long-course chemoradiotherapy before total mesorectal excision for locally advanced rectal tumors: A single-center study in Taiwan utilizing propensity score matching Open
Background: Locally advanced rectal tumors are typically treated with neoadjuvant chemoradiotherapy. Short-course chemoradiotherapy (SCRT, 2500 cGy in five fractions) is a convenient alternative to concurrent chemoradiotherapy with long-co…
View article: Combination of Modest Dosage of Bevacizumab with TAS-102 Provided the Comparable Efficacy in Treating Refractory Metastatic Colorectal Cancer
Combination of Modest Dosage of Bevacizumab with TAS-102 Provided the Comparable Efficacy in Treating Refractory Metastatic Colorectal Cancer Open
Background Given that the combination of bevacizumab and TAS-102 is used to treat refractory metastatic colorectal cancer (mCRC), we aimed to evaluate the efficacy of modest doses of bevacizumab in combination with TAS-102 for the treatmen…
View article: Decreased interleukin‐ <scp>17RA</scp> expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice
Decreased interleukin‐ <span>17RA</span> expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice Open
Background Interleukin‐17 (IL‐17) is a pro‐inflammatory cytokine that plays a vital role in the promotion of tumorigenesis in various cancers, including colorectal cancer (CRC). Based on current evidence, IL‐17 binds to interleukin‐17 rece…
View article: Detecting microsatellite instability in colorectal cancer using Transformer-based colonoscopy image classification and retrieval
Detecting microsatellite instability in colorectal cancer using Transformer-based colonoscopy image classification and retrieval Open
Colorectal cancer (CRC) is a major global health concern, with microsatellite instability-high (MSI-H) being a defining characteristic of hereditary nonpolyposis colorectal cancer syndrome and affecting 15% of sporadic CRCs. Tumors with MS…
View article: The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study
The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study Open
View article: Surgical strategy for colorectal cancer with synchronous liver and extrahepatic metastases: A scoring system and decision tree model
Surgical strategy for colorectal cancer with synchronous liver and extrahepatic metastases: A scoring system and decision tree model Open
Background: The role of hepatectomy in a specific group of patients with synchronous colorectal cancer with liver metastases (SCRLM) and synchronous extrahepatic disease (SEHD) is still unclear. The aim of this study was to evaluate the ef…
View article: Decreased interleukin-17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice
Decreased interleukin-17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice Open
Background Interleukin-17 (IL-17) is a proinflammatory cytokine that plays a vital role in the promotion of tumorigenesis in various cancers, including colorectal cancer (CRC). Based on current evidence, IL-17 binds to interleukin-17 recep…
View article: Supplementary Figure Legends from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure Legends from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 104KB
View article: Supplementary Figure 4 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 4 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 177KB, The serum profiles of various cytokines in mice with or without metastasis.
View article: Supplementary Figure 5 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 5 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 64KB, Treatment with rGM-CSF decreased CTCs and inhibited metastasis.
View article: Supplementary Table 1 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Table 1 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 126KB, Clinicopathological characteristics of the patients analyzed in this study.
View article: Supplementary Table 2 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Table 2 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 65KB, Pretherapy serum levels of cytokines in patients with and without recurrence.
View article: Supplementary Figure 2 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 2 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 248KB, The number of CTCs detected from forearm vein of clinical stage I/II lung cancer patients are higher than those of stages III and IV.
View article: Supplementary Table 2 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Table 2 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 65KB, Pretherapy serum levels of cytokines in patients with and without recurrence.
View article: Supplementary Figure 10 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 10 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 846KB, Expression of IL-17A was higher CRC with recurrence.
View article: Supplementary Figure 1 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 1 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 590KB, CTCs are more abundant in blood from the mesenteric vein than in blood from the forearm vein.
View article: Supplementary Figure 2 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 2 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 248KB, The number of CTCs detected from forearm vein of clinical stage I/II lung cancer patients are higher than those of stages III and IV.
View article: Supplementary Figure 8 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 8 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 76KB, GM-CSF facilitates CTC clearance by boosting host immunity.
View article: Supplementary Figure 7 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 7 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 261KB, MMP9 is up-regulated in the inoculated tumors of IL-17A-depelting mice.
View article: Supplementary Figure 9 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 9 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 116KB, Expression of IL-17A was positively correlated with MMP9 and VEGF.
View article: Supplementary Figure 8 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 8 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 76KB, GM-CSF facilitates CTC clearance by boosting host immunity.
View article: Supplementary Table 1 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Table 1 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 126KB, Clinicopathological characteristics of the patients analyzed in this study.
View article: Supplementary Figure 7 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 7 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 261KB, MMP9 is up-regulated in the inoculated tumors of IL-17A-depelting mice.
View article: Supplementary Figure 5 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Supplementary Figure 5 from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
PDF file - 64KB, Treatment with rGM-CSF decreased CTCs and inhibited metastasis.
View article: Data from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases
Data from Interleukin-17A Modulates Circulating Tumor Cells in Tumor Draining Vein of Colorectal Cancers and Affects Metastases Open
Purpose: Metastasis is the major cause of death in patients with colorectal cancer (CRC). Circulating tumor cells (CTC) are believed to cause metastasis and serve as a prognostic marker for mortality in clinical stage IV patients. H…